Summary

  • Aon agreed to acquire USI for US$17.0 billion in cash, subject to the merger agreement's adjustments. It presents a US$16.7 billion net price after about US$278 million of estimated tax attributes that remain subject to realisation.
  • The advertised 14.5x multiple divides that net price by US$1.151 billion of synergized adjusted EBITDA: US$995 million of seller adjusted EBITDA, less US$239 million of buyer adjustments, plus US$115 million of revenue-synergy EBITDA and US$280 million of cost synergies.
  • The US$395 million synergy contribution is a full-run-rate estimate expected to be substantially realised between closing and 2029. It is not current earnings. Aon separately expects adjusted EPS dilution in 2027 and accretion from 2028.
  • New debt is expected to fund the all-cash deal. Aon projects leverage of about 4.8x at close and a return to 2.8–3.0x in roughly 24 months, while pausing near-term buybacks and maintaining its dividend priority.

A multiple with a maturity date

Aon's 31 August transaction announcement gives the headline: US$17.0 billion to acquire USI from KKR and other shareholders, or US$16.7 billion on a net basis after reflecting roughly US$278 million of certain tax attributes. It then labels the net price approximately 14.5 times synergized trailing-twelve-month adjusted EBITDA.

Those descriptions are not interchangeable. The merger agreement establishes the contractual purchase price and adjustment machinery. The US$278 million is Aon's estimate of tax attributes that may provide future benefits, subject to future realisation. It is neither cash already received nor a guaranteed reduction in the cash paid at closing.

The denominator has an even clearer time condition. Aon defines synergized adjusted EBITDA using the full benefit of targeted run-rate cost and net-revenue synergies expected to be substantially realised between the anticipated closing date and 2029. The deal is expected to close in the fourth quarter of 2026, subject to regulatory approval and customary conditions. Until then the companies remain independent, and the synergy programme has not begun as a combined operation.

The receipt behind 14.5x

The transaction presentation makes the bridge unusually explicit. USI produced US$3.0 billion of revenue and US$995 million of seller adjusted EBITDA for the twelve months ended 30 June 2026. Aon then removes US$60 million of revenue and US$239 million of adjusted EBITDA through buyer adjustments. It adds US$321 million of targeted net revenue synergies, whose stated EBITDA effect is US$115 million, and US$280 million of targeted cost synergies. The resulting columns show US$3.261 billion of revenue and US$1.151 billion of adjusted EBITDA.

US$16.7 billion divided by US$1.151 billion is about 14.5x. For comparison, BTW arithmetic on the disclosed inputs gives roughly 16.8x against the seller's US$995 million adjusted EBITDA and about 22.1x against the US$756 million left after buyer adjustments but before synergies. Aon does not present those two ratios as transaction multiples. They are useful because they show how much of the advertised compression comes from redefining the starting earnings base and how much comes from future value capture.

The US$239 million reduction matters. The buyer reverses seller adjustments for restructuring, incremental producer investments and other seller-specific items, including some non-cash compensation, innovation spending and acquisition-related costs. This is not a synergy credit. It lowers the accepted stand-alone base before any combination benefit is added.

The revenue line also needs discipline. Aon targets US$381 million of gross revenue synergies and US$321 million net, but attributes only US$115 million of adjusted EBITDA to the net revenue figure. Treating US$321 million as EBITDA would overstate the denominator. The other US$280 million is the targeted adjusted-EBITDA impact of cost synergies. Together, and only at full run rate, they form the US$395 million addition.

Four clocks start at different points

Synergy realisation is one clock. Aon says implementation begins on day one after closing and expects the benefits to be substantially realised by 2029. The cost clock arrives earlier: US$160 million of estimated transaction costs, US$550 million of integration costs with the majority completed by the end of 2028, and as much as US$400 million of retention and performance incentives spread over three years.

The accounting outcome has a third cadence. Aon expects the acquisition to dilute adjusted earnings per share in 2027, then become accretive in 2028 and thereafter. That sequence is consistent with costs and financing preceding the full benefit, but adjusted-EPS accretion is not proof that every synergy has become recurring cash flow.

The balance sheet supplies the fourth clock. Aon expects to fund the all-cash consideration and associated costs with new debt issued across a range of maturities, subject to market conditions. Its presentation indicates leverage of about 4.8x at close, including the impact of restructuring, and an objective of 2.8–3.0x within approximately 24 months. The 4.8x is a forecast for closing, not Aon's current ratio.

At 30 June, before signing, Aon's Form 10-Q reported US$1.062 billion of cash and US$205 million of short-term investments. Current debt was US$2.020 billion and long-term debt US$12.947 billion. Two revolving facilities provided US$2.0 billion of aggregate available commitments. These figures frame capacity; they are not the transaction's final funding stack.

Capital returns become part of the price

Aon's second-quarter release shows US$986 million of operating cash flow and US$846 million of free cash flow in the first half of 2026. Over the same period it repurchased US$1.1 billion of shares and paid US$337 million of dividends. At June's end, US$7.7 billion remained under its repurchase authorisation.

The acquisition announcement says Aon does not expect to repurchase shares in the near term as it prioritises debt repayment, while continuing to fund a stable and growing dividend. That is a change in expected deployment, not cancellation of the authorisation. The opportunity cost of the purchase therefore includes the equity that will not be retired while cash is directed to interest, integration and deleveraging.

For creditors, the test is whether synergy conversion and free cash flow reduce the numerator fast enough to protect the stated ratings. For shareholders, the test is stricter: the combination must first absorb costs and dilution, then create more durable per-share value than the postponed buybacks would have delivered.

The label is an underwriting claim, not a closing fact

The 14.5x figure is mathematically traceable and economically conditional. Its numerator uses a net value that depends partly on tax benefits. Its denominator begins below the seller's adjusted measure, then includes a full US$395 million of future synergy EBITDA. Aon also states that the forward-looking measure has not been prepared under Regulation S-X pro-forma requirements and is not reconciled because doing so would imply a precision management says it cannot provide.

That does not make the measure useless. It makes the receipt more important. A professional reader should carry at least three denominators: seller adjusted EBITDA, buyer-adjusted stand-alone EBITDA and realised combined EBITDA. The transaction earns its headline multiple only as the third approaches US$1.151 billion without sacrificing clients, producers, service quality or the cash needed to reduce debt.

Sources